During the past decade, SPb SHI "City Hospital #9" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SPb SHI "City Hospital #9"" are "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "SPb SHI "City Hospital #9"" in a lesser frequency.

Most popular intervention types in "SPb SHI "City Hospital #9"" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Etrolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "SPb SHI "City Hospital #9"" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SPb SHI "City Hospital #9"". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SPb SHI "City Hospital #9", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SPb SHI "City Hospital #9", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".